- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort ; volume:13 ; number:1 ; day:18 ; month:8 ; year:2022 ; pages:1-8 ; date:12.2022
Nature Communications ; 13, Heft 1 (18.8.2022), 1-8, 12.2022
- Urheber
-
Aldridge, Robert W.
Yavlinsky, Alexei
Nguyen, Vincent
Eyre, Max T.
Shrotri, Madhumita
Navaratnam, Annalan M. D.
Beale, Sarah
Braithwaite, Isobel
Byrne, Thomas
Kovar, Jana
Fragaszy, Ellen
Fong, Wing Lam Erica
Geismar, Cyril
Patel, Parth
Rodger, Alison
Johnson, Anne M.
Hayward, Andrew
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-32265-5
- URN
-
urn:nbn:de:101:1-2022110512302011231826
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aldridge, Robert W.
- Yavlinsky, Alexei
- Nguyen, Vincent
- Eyre, Max T.
- Shrotri, Madhumita
- Navaratnam, Annalan M. D.
- Beale, Sarah
- Braithwaite, Isobel
- Byrne, Thomas
- Kovar, Jana
- Fragaszy, Ellen
- Fong, Wing Lam Erica
- Geismar, Cyril
- Patel, Parth
- Rodger, Alison
- Johnson, Anne M.
- Hayward, Andrew
- SpringerLink (Online service)
Ähnliche Objekte (12)
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections
Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein
Breakthrough infections in MPN-COVID vaccinated patients
Breakthrough infections in MPN-COVID vaccinated patients
An Update on Breakthrough Invasive Mold Infections
Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization
Association between levels of receptor binding domain antibodies of SARS-CoV-2, receipt of booster and risk of breakthrough infections: LA pandemic surveillance cohort study
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections
Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein
Breakthrough infections in MPN-COVID vaccinated patients
Breakthrough infections in MPN-COVID vaccinated patients
An Update on Breakthrough Invasive Mold Infections
Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization
Association between levels of receptor binding domain antibodies of SARS-CoV-2, receipt of booster and risk of breakthrough infections: LA pandemic surveillance cohort study
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections
Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein
Breakthrough infections in MPN-COVID vaccinated patients
Breakthrough infections in MPN-COVID vaccinated patients
An Update on Breakthrough Invasive Mold Infections
Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization
Association between levels of receptor binding domain antibodies of SARS-CoV-2, receipt of booster and risk of breakthrough infections: LA pandemic surveillance cohort study